Satheesh Balasubramanian

Title: Innovations by Satheesh Balasubramanian

Introduction

Satheesh Balasubramanian is a notable inventor based in Hyderabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable liquid compositions for medicinal use. With a total of 2 patents, his work focuses on enhancing the efficacy and stability of pharmaceutical formulations.

Latest Patents

His latest patents include the development of stable pharmaceutical compositions of clonidine. This invention relates to liquid pharmaceutical compositions of clonidine or its pharmaceutically acceptable salts, which are suitable for oral administration and stable for extended periods. Specifically, these compositions maintain stability at concentrations of 1 μg/mL or more. Additionally, he has patented stable pharmaceutical compositions of bendamustine. These injectable compositions are designed as ready-to-dilute or ready-to-use formulations for intravenous administration, ensuring they are antioxidant-free and suitable for parenteral use.

Career Highlights

Satheesh Balasubramanian is currently associated with Azurity Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work is pivotal in creating formulations that improve patient outcomes and streamline the administration of medications.

Collaborations

He collaborates with talented professionals such as Sumitra Ashokkumar Pillai and Harish Govindaraja Setty Chinnari, contributing to a dynamic research environment that fosters innovation.

Conclusion

Satheesh Balasubramanian's contributions to pharmaceutical innovations highlight his commitment to improving healthcare through effective drug formulations. His patents reflect a deep understanding of pharmaceutical science and a dedication to enhancing patient care.